Conclusions: Many healthy babies have glucose concentrations below the recommended thresholds for treatment of hypoglycaemia in at risk babies. Background: Blood glucose screening is recommended for babies identified as being at risk for neonatal hypoglycaemia, but not for healthy term babies. We compared the incidence of low glucose concentrations in the first 48 h after birth between healthy term babies and term babies identified as being at risk for hypoglycaemia.
INCIDENCE OF HYPOGLYCAEMIA ARE AS COMMON IN HEALTHY TERM BABIES AS IN BABIES IDENTIFIED AS BEING AT RISK: THE GLUCOSE IN WELL BABIES (GLOW) STUDY
Methods: Healthy babies were appropriately grown singletons. Participants and researchers were unaware of the glucose results. At-risk babies were small (<10 th centile or <2.5 kg) or large (>90 th centile or >4.5 kg) or infants of diabetic mothers. Clinicians were aware of blood but not interstitial glucose results and treated with the aim of keeping blood glucose concentrations ≥ 2.6 mM.
Results: 67 healthy and 326 at-risk babies were included in the analysis. Healthy babies had fewer blood glucose measurements than at-risk babies (median (range) 6 (4-7) vs 8 (1-22), P < 0.001). The number of babies with episodes of low glucose concentrations was similar in both groups (Table) . Dextrose gel has been widely adopted for treatment of neonatal hypoglycaemia. Although it appeared safe to 2 years, effects on subtle neurocognitive processes require assessment at older ages.
Methods: At-risk hypoglycaemic babies (<2.6 mM) were randomised to 40% dextrose or placebo gel (0.5 ml/kg) and fed. Survivors were assessed at 4.5 years. Primary outcome was neurosensory impairment: any of cerebral palsy; visual impairment; deafness; IQ <85; Beery visual-motor integration score <85; Movement ABC score <15 th centile; low executive function or motion coherence threshold (worse than 1.5 SD from the mean). Secondary outcomes included components of the primary outcome, measures of behaviour, vision, hearing and general health.
Results: Of the 237 babies randomised, 185(78%) children were followed up; 96 randomised to dextrose and 89 to placebo gel. Neurosensory impairment was present in 70 children (38%) with similar rates in both groups (dextrose 38% vs placebo 39%, relative risk [RR] 0.97, 95% CI 0.72, 1.29, P=0.83 
